Oriented at the cutting edge of AI, RNA and structural biology

Executed by an interdisciplinary, world-class team with deep experience in RNA and structural biology, artificial intelligence, machine learning, genomics, engineering, and physics, we are THE RNA structure company. We value care, boldness, results-focus, teamwork and growth mindset.

Executed by an interdisciplinary, world-class team with deep experience in RNA and structural biology, artificial intelligence, machine learning, genomics, engineering, and physics, we are THE RNA structure company. We value care, boldness, results-focus, teamwork and growth mindset.

Raphael Townshend

Founder & CEO

Manjunath Ramarao

Chief Scientific Officer

Mark Stead

Head of Business
Development

Stephan Eismann

Founding Scientist,
Head of Machine Learning

Brent Townshend

Head of ML Data Generation

Stephanie Simmons

Head of People

Esta Kor

Business Operations
Manager

Praveen Kumar

Screening Lead

Minna Bui

Staff Scientist, Chemistry

Derek Leung

Strategy & Finance Intern

Meredith Corley

Senior Scientist,
Computational Biology

Brandon Anderson

Staff Scientist,
Machine Learning

Yuzu Ido

Machine Learning Engineer

Cornelius Corkery

Operations & Compliance
Specialist

Suparna Gupta

Project Management Lead

Gabriel Ferns

Machine Learning Engineer

Debarati DasGupta

Senior Scientist,
Computational Chemistry

Connor Stephens

Machine Learning Engineer

Ryan Chow

Associate Scientist

Matias Kaplan

Founding Scientist,
RNA Biology

Ramya Rangan

Scientist, Computational
Structural Biology


Nicholas Meanwell

Former Scientific VP of Small Molecule Drug Discovery at Bristol-Myers Squibb

Advanced 33 clinical candidates over a 40-year career at BMS.

Amanda Garner

Associate Professor, Medicinal Chemistry, University of Michigan

Works to unlock the druggability of RNA by bridging chemistry and biology.

Gene Yeo

Professor of Cellular and Molecular Medicine, UCSD

His research focuses on the importance of RNA processing and the roles that RNA binding proteins play in development and disease.

Ron Dror

Professor of Computer Science, Stanford University

Leads a research group that uses molecular simulation and machine learning to elucidate biomolecular structure, dynamics, and function.

Percy Carter

CSO of Blueprint Medicines and Board Member of HiFiBiO Therapeutics

Previous scientific leadership roles at Fibrogen, Janssen, and BMS.